Robert Gross, MD, MSCE
Professor of Medicine
Department: Medicine
Contact information
804 Blockley Hall
Center for Clinical Epidemiology and Biostatistics
University of Pennsylvania, Perelman School of Medicine
423 Guardian Drive
Philadelphia, PA 19104-6021
Center for Clinical Epidemiology and Biostatistics
University of Pennsylvania, Perelman School of Medicine
423 Guardian Drive
Philadelphia, PA 19104-6021
Office: 215-898-2437
Fax: 215-573-5315
Fax: 215-573-5315
Publications
Education:
BA (Italian)
Cornell University , 1986.
MD
Cornell University, 1991.
MSCE (Pharmacoepidemiology)
University of Pennsylvania, 2000.
BA (Italian)
Cornell University , 1986.
MD
Cornell University, 1991.
MSCE (Pharmacoepidemiology)
University of Pennsylvania, 2000.
Links
Search PubMed for articles
Center for Clinical Epidemiology and Biostatistics faculty webpage.
Permanent linkSearch PubMed for articles
Center for Clinical Epidemiology and Biostatistics faculty webpage.
Selected Publications
Mannathoko N, Mosepele M, Gross R, Smith R, Alby K, Glaser L,Richard-Greenblatt M, Sharma A,Jaskowiak-Barr A, Cressman L, Sewawa K, Cowden L, Reesey E, Otukile D, Paganotti G, Mokomane M, Lautenbach E : Colonization with Extended-Spectrum Cephalosporin-Resistant Enterobacterales (ESCrE) and Carbapenem-Resistant Enterobacterales (CRE) in Healthcare and Community Settings in Botswana: An Antibiotic Resistance in Communities and Hospitals (ARCH) Study International Journal of Infectious Diseases 2022 (in press).Martei YM, Narasimhamurthy M, Setlhako DI, Ayane G, Ralefala T, Chiyapo S, Gross R, Shulman LN, Grover S, DeMichele A : Relative Dose Intensity and Pathologic Response Rates in Breast Cancer Patients with and without HIV Who Received Neoadjuvant Chemotherapy JCO Global Oncology 2022 (in press).
Sanchez AL, Hoskins K, Pettit AR, Momplaisir F, Gross R, Brady KA, Hoffacker C, Zentgraf K, Beidas RS: Stakeholder Perspectives on Implementing an Evidence-Based Behavioral Intervention for People with HIV: A Rapid Qualitative Analysis of Implementation Determinants JAIDS 2022 (in press).
Motlokwa PK, Tsima BM, Martei YM, Ralefala T, Galebole F, Stephens-Shields AJ, Grover S,* Gross R* * equal contribution by authors : Disparities in Oral Cancer Stage at Presentation in a High HIV Prevalence Setting in Sub-Saharan Africa JCO Global Oncology 2022 (in press).
Avihingsanon A, Hughes MD, Salata R, Godfrey C, McCarthy C, Mugyenyi P, Hogg E, Gross R, Cardoso SW, Bukuru A, Makanga M, Badal-Faesen S, Mave V, Wangari Ndege B, Nerette Fontain S, Samaneka W, Secours R, Van Schalkwyk M, Mngqibisa R, Mohapi L, Valencia J, Sugandhavesa P, Montalban E, Munyanga C, Chagomerana M, Santos BR, Kumarasamy N, Kanyama C, Schooley RT, Mellors JW, Wallis CL, Collier AC, Grinsztejn B for the A5288 Study team: Third-line antiretroviral therapy including raltegravir (RAL), darunavir (DRV/r) and/or etravirine (ETR) is well tolerated and achieves durable virologic suppression over 144+ weeks in resource limited settings: ACTG A5288 strategy trial. Journal of the International AIDS Society 2022 (in press).
O'Brien TC, Feinberg J, Gross R, Albarracin D: Supportive environments during the substance use disorder epidemic in the rural United States: Provider support for interventions and expectations of interactions with providers. Social Science & Medicine 2022 (in press).
Schnoll R, Bernstein SL, Kaufman A, Gross R, Catz S, Cioe P, Hitsman R, Marhefka SL, Pacek L, Vidrine D, Vilardaga R, Edelman EJ, McClure J, Ashare R, Lockhart E, Crothers K: COVID-19 challenges confronted by smoking cessation clinical trials for people living with HIV: The experience of grantees of the United States National Cancer Institute. Nicotine and Tobacco Research 2021 (in press).
Bien-Gund C, Shah J, Ho J, Shea K, Dugosh K, Gross R: The COVID-19 Self-Testing through Rapid Network Distribution (C-STRAND) trial: A randomized controlled trial to increase COVID-19 testing in underserved populations Contemporary Clinical Trials 2021 (in press).
Lowenthal ED, Ohrenshall R, Moshashane N, Bula B, Chapman J, Marukutira TC, Tshume O, Gross R, Mphele S. : Reasons for Discordance between Antiretroviral Adherence Measures in Adolescents. AIDS Care 2021 (in press).
Mantshonyane L, Roy J, Levy MZ, Wallis CL, Bar K, Godfrey C, Collier A, LaRosa A, Zheng L, Sun X, Gross R: Participants switching to second-line antiretroviral therapy with susceptible virus display inferior adherence and worse outcomes: an observational analysis of prospectively collected data AIDS Patient Care and STDs 2021 (in press).